EFFICACY RESPONSE DURATION AND TOXICITY OF RITUXIMAB, FLUDARABINE, AND CYCLOPHOSPHAMIDE (RFC) AS 1ST LINE TREATMENT AND RITUXIMAB (R) IN MAINTENANCE TREATMENT IN FOLLICULAR NON HODGKIN (FNH) LYMPHOMA: